Annual EBITDA
-$35.77 M
-$3.89 M-12.20%
31 December 2023
Summary:
XBiotech annual earnings before interest, taxes, depreciation & amortization is currently -$35.77 million, with the most recent change of -$3.89 million (-12.20%) on 31 December 2023. During the last 3 years, it has fallen by -$19.73 million (-123.01%). XBIT annual EBITDA is now -291.27% below its all-time high of -$9.14 million, reached on 31 December 2013.XBIT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$4.36 M
+$10.17 M+69.97%
30 September 2024
Summary:
XBiotech quarterly earnings before interest, taxes, depreciation & amortization is currently -$4.36 million, with the most recent change of +$10.17 million (+69.97%) on 30 September 2024. Over the past year, it has increased by +$2.26 million (+34.12%). XBIT quarterly EBITDA is now -170.55% below its all-time high of -$1.61 million, reached on 31 March 2020.XBIT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$46.81 M
+$2.26 M+4.61%
30 September 2024
Summary:
XBiotech TTM earnings before interest, taxes, depreciation & amortization is currently -$46.81 million, with the most recent change of +$2.26 million (+4.61%) on 30 September 2024. Over the past year, it has dropped by -$12.95 million (-38.22%). XBIT TTM EBITDA is now -1910.00% below its all-time high of -$2.33 million, reached on 31 December 2013.XBIT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.2% | +34.1% | -38.2% |
| 3 y3 years | -123.0% | -43.4% | -130.8% |
| 5 y5 years | -92.7% | +20.9% | -116.5% |
XBIT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -123.0% | at low | -43.4% | +75.1% | -130.8% | +4.6% |
| 5 y | 5 years | -123.0% | at low | -170.6% | +75.1% | -191.9% | +4.6% |
| alltime | all time | -291.3% | +31.3% | -170.6% | +75.1% | -1910.0% | +10.1% |
XBiotech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.36 M(-70.0%) | -$46.81 M(-4.6%) |
| June 2024 | - | -$14.53 M(+39.4%) | -$49.07 M(+3.6%) |
| Mar 2024 | - | -$10.42 M(-40.4%) | -$47.37 M(+8.5%) |
| Dec 2023 | -$35.77 M(+12.2%) | -$17.50 M(+164.1%) | -$43.65 M(+28.9%) |
| Sept 2023 | - | -$6.62 M(-48.3%) | -$33.87 M(+2.9%) |
| June 2023 | - | -$12.82 M(+91.3%) | -$32.90 M(+4.6%) |
| Mar 2023 | - | -$6.70 M(-13.2%) | -$31.44 M(-1.4%) |
| Dec 2022 | -$31.88 M(+42.1%) | -$7.72 M(+36.5%) | -$31.88 M(+4.0%) |
| Sept 2022 | - | -$5.66 M(-50.3%) | -$30.65 M(+9.3%) |
| June 2022 | - | -$11.37 M(+59.3%) | -$28.04 M(+5.3%) |
| Mar 2022 | - | -$7.13 M(+9.9%) | -$26.64 M(+18.7%) |
| Dec 2021 | -$22.43 M(+39.9%) | -$6.49 M(+113.3%) | -$22.43 M(+10.6%) |
| Sept 2021 | - | -$3.04 M(-69.5%) | -$20.28 M(-5.0%) |
| June 2021 | - | -$9.97 M(+239.9%) | -$21.36 M(+23.0%) |
| Mar 2021 | - | -$2.93 M(-32.4%) | -$17.36 M(+8.2%) |
| Dec 2020 | -$16.04 M(-44.5%) | -$4.34 M(+5.2%) | -$16.04 M(-34.4%) |
| Sept 2020 | - | -$4.12 M(-30.9%) | -$24.45 M(-5.4%) |
| June 2020 | - | -$5.97 M(+270.0%) | -$25.84 M(+2.2%) |
| Mar 2020 | - | -$1.61 M(-87.3%) | -$25.28 M(-12.4%) |
| Dec 2019 | -$28.87 M | -$12.74 M(+131.1%) | -$28.87 M(+33.6%) |
| Sept 2019 | - | -$5.51 M(+2.0%) | -$21.62 M(+4.9%) |
| June 2019 | - | -$5.41 M(+4.0%) | -$20.60 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$5.20 M(-5.2%) | -$20.20 M(+8.8%) |
| Dec 2018 | -$18.56 M(-43.0%) | -$5.49 M(+22.1%) | -$18.56 M(-7.1%) |
| Sept 2018 | - | -$4.50 M(-10.3%) | -$19.98 M(-8.3%) |
| June 2018 | - | -$5.01 M(+40.7%) | -$21.78 M(-16.7%) |
| Mar 2018 | - | -$3.56 M(-48.5%) | -$26.16 M(-19.7%) |
| Dec 2017 | -$32.58 M(-37.4%) | -$6.91 M(+9.8%) | -$32.57 M(-22.3%) |
| Sept 2017 | - | -$6.30 M(-33.0%) | -$41.93 M(-12.5%) |
| June 2017 | - | -$9.39 M(-5.8%) | -$47.92 M(-7.8%) |
| Mar 2017 | - | -$9.97 M(-38.7%) | -$51.97 M(-0.2%) |
| Dec 2016 | -$52.06 M(+41.4%) | -$16.27 M(+32.4%) | -$52.06 M(+9.2%) |
| Sept 2016 | - | -$12.28 M(-8.6%) | -$47.68 M(+3.6%) |
| June 2016 | - | -$13.44 M(+33.5%) | -$46.04 M(+18.5%) |
| Mar 2016 | - | -$10.07 M(-15.3%) | -$38.84 M(+5.5%) |
| Dec 2015 | -$36.81 M(+74.3%) | -$11.88 M(+11.6%) | -$36.81 M(+18.4%) |
| Sept 2015 | - | -$10.64 M(+70.5%) | -$31.09 M(+14.0%) |
| June 2015 | - | -$6.25 M(-22.3%) | -$27.28 M(+10.0%) |
| Mar 2015 | - | -$8.04 M(+30.6%) | -$24.79 M(+17.4%) |
| Dec 2014 | -$21.11 M(+131.0%) | -$6.16 M(-9.9%) | -$21.11 M(+22.2%) |
| Sept 2014 | - | -$6.83 M(+81.8%) | -$17.29 M(+65.4%) |
| June 2014 | - | -$3.76 M(-13.8%) | -$10.45 M(+56.2%) |
| Mar 2014 | - | -$4.36 M(+87.3%) | -$6.69 M(+187.3%) |
| Dec 2013 | -$9.14 M(-35.7%) | -$2.33 M | -$2.33 M |
| Dec 2012 | -$14.22 M | - | - |
FAQ
- What is XBiotech annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for XBiotech?
- What is XBiotech annual EBITDA year-on-year change?
- What is XBiotech quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for XBiotech?
- What is XBiotech quarterly EBITDA year-on-year change?
- What is XBiotech TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for XBiotech?
- What is XBiotech TTM EBITDA year-on-year change?
What is XBiotech annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of XBIT is -$35.77 M
What is the all time high annual EBITDA for XBiotech?
XBiotech all-time high annual earnings before interest, taxes, depreciation & amortization is -$9.14 M
What is XBiotech annual EBITDA year-on-year change?
Over the past year, XBIT annual earnings before interest, taxes, depreciation & amortization has changed by -$3.89 M (-12.20%)
What is XBiotech quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of XBIT is -$4.36 M
What is the all time high quarterly EBITDA for XBiotech?
XBiotech all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.61 M
What is XBiotech quarterly EBITDA year-on-year change?
Over the past year, XBIT quarterly earnings before interest, taxes, depreciation & amortization has changed by +$2.26 M (+34.12%)
What is XBiotech TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of XBIT is -$46.81 M
What is the all time high TTM EBITDA for XBiotech?
XBiotech all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.33 M
What is XBiotech TTM EBITDA year-on-year change?
Over the past year, XBIT TTM earnings before interest, taxes, depreciation & amortization has changed by -$12.95 M (-38.22%)